Literature DB >> 21528298

Differential immunohistochemical localization of xanthine oxidase in normal and neoplastic human breast epithelium.

W Cook1, R Chu, M Saksela, K Raivio, A Yeldandi.   

Abstract

Xanthine oxidase (XO) and xanthine dehydrogenase (XDH) are alternate enzymatic forms of the XO/XDH protein that catalyzes the oxidation of hypoxanthine to xanthine, and xanthine to uric acid, and in the process XO/XDH generates reactive oxygen species (ROS) such as superoxide, hydrogen peroxide, and hydroxyl radicals. We hypothesize that XO/XDH, which is expressed in mammary epithelium, contributes to the development of breast cancers by virtue of its ability to generate genotoxic ROS. In this study, we produced human XO/XDH protein at high levels in Spodoptera frugiperda (Sf9) insect cells using the baculovirus vector to confirm the specificity of antibodies used for immunostaining of human breast tissues. Immunoblot analysis demonstrated that the full length 143 kDa polypeptide was partially processed into a 87 kDa and 59 kDa fragments. The overexpressed XO/XDH protein was identified in the cytoplasm of insect cells by immunofluorescence staining. Using these antibodies we analyzed normal and neoplastic breast epithelium for the presence of XO/XDH. Immunohistochemical analysis of normal human breast revealed the presence of XO/XDH in the cytoplasm of epithelium lining terminal ducts. The intensity of XO/XDH staining was markedly enhanced in alveolar epithelium of lactating mammary lobules. In contrast, no immunohistochemically detectable XO/XDH was observed in intraductal in situ carcinomas and in invasive carcinomas of the breast. Further studies are necessary to confirm the utility of the loss of XO/XDH expression as a marker for neoplastic change in the breast and investigate the functional role of this enzyme in the pathogenesis of breast cancer.

Entities:  

Year:  1997        PMID: 21528298     DOI: 10.3892/ijo.11.5.1013

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  7 in total

1.  Decreased xanthine oxidoreductase is a predictor of poor prognosis in early-stage gastric cancer.

Authors:  N Linder; C Haglund; M Lundin; S Nordling; A Ristimäki; A Kokkola; J Mrena; J-P Wiksten; J Lundin
Journal:  J Clin Pathol       Date:  2006-09       Impact factor: 3.411

2.  Contribution of xanthine oxidoreductase to mammary epithelial and breast cancer cell differentiation in part modulates inhibitor of differentiation-1.

Authors:  Mehdi A Fini; Jenifer Monks; Susan M Farabaugh; Richard M Wright
Journal:  Mol Cancer Res       Date:  2011-07-20       Impact factor: 5.852

3.  Prolonged fasting increases purine recycling in post-weaned northern elephant seals.

Authors:  José Guadalupe Soñanez-Organis; José Pablo Vázquez-Medina; Tania Zenteno-Savín; Andres Aguilar; Daniel E Crocker; Rudy M Ortiz
Journal:  J Exp Biol       Date:  2012-05-01       Impact factor: 3.312

4.  Establishing pteridine metabolism in a progressive isogenic breast cancer cell model.

Authors:  Lindsey Rasmussen; Zachary Foulks; Casey Burton; Honglan Shi
Journal:  Metabolomics       Date:  2021-12-17       Impact factor: 4.290

Review 5.  The double faced role of xanthine oxidoreductase in cancer.

Authors:  Man-Man Chen; Ling-Hua Meng
Journal:  Acta Pharmacol Sin       Date:  2021-11-22       Impact factor: 7.169

6.  Migratory activity of human breast cancer cells is modulated by differential expression of xanthine oxidoreductase.

Authors:  Mehdi A Fini; David Orchard-Webb; Beata Kosmider; Jeremy D Amon; Robert Kelland; Gayle Shibao; Richard M Wright
Journal:  J Cell Biochem       Date:  2008-11-01       Impact factor: 4.429

Review 7.  Xanthine oxidoreductase in cancer: more than a differentiation marker.

Authors:  Maria Giulia Battelli; Letizia Polito; Massimo Bortolotti; Andrea Bolognesi
Journal:  Cancer Med       Date:  2015-12-21       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.